BridgeMD
New treatment option for Dementia, Mild
Official title Autonomic Involvement in Patient With Cognitive Decline
ClinicalTrials.gov ID: NCT06292741
What this study is testing
- What it's testing
- Prospective interventional study with a device for comparing autonomic parameters among patients with different forms of cognitive decline
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 85
You may be able to join if
- male and females between 50 and 85 years
- cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia)
- mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI)
- Ability to assume the upright position
You likely can't join if
- diabetes mellitus
- eye problems
- severe cognitive decline
- heart disease
- peripheral neuropathy
- language barrier
See the full eligibility criteria
- male and females between 50 and 85 years
- cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia)
- mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI)
- Ability to assume the upright position
- diabetes mellitus
- eye problems
- severe cognitive decline
- heart disease
- peripheral neuropathy
- language barrier
- oncological disease
- medical pathologies associated with cognitive deficits
The study team makes the final eligibility decision.
Where it's taking place
- Rome, Lazio, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rome, Lazio, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.